Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
Identifieur interne : 004094 ( Main/Exploration ); précédent : 004093; suivant : 004095Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
Auteurs : Emma Mcintosh [Royaume-Uni] ; Alastair Gray [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-09.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Advanced stage, Cost efficiency analysis, Cost estimation, Costs, Data Collection, Electric Stimulation Therapy, Electrical stimulus, Electrodes, Implanted, Health Care Costs, Health economy, Hospitals (statistics & numerical data), Human, Humans, Instrumentation therapy, Neurosurgical Procedures (economics), Parkinson Disease (economics), Parkinson Disease (surgery), Parkinson disease, Parkinson's disease, Severity of Illness Index, Subthalamic Nucleus (surgery), Subthalamic nucleus, Treatment Outcome, United Kingdom, cost, subthalamic stimulation.
- MESH :
- economics : Neurosurgical Procedures, Parkinson Disease.
- statistics & numerical data : Hospitals.
- surgery : Parkinson Disease, Subthalamic Nucleus.
- Data Collection, Electric Stimulation Therapy, Electrodes, Implanted, Health Care Costs, Humans, Severity of Illness Index, Treatment Outcome.
Abstract
We estimated the current cost of deep brain stimulation surgery targeted on the subthalamic nucleus. The method used was a cost analysis using typical resource use patterns and unit costs from a leading surgical centre, detailed equipment costs from the manufacturer, and sensitivity analysis. Resource use was based on patients with advanced Parkinson's disease. The main outcome measure was the likely total health service costs per patient, including preoperative assessment, surgery, and postoperative management over a 5‐year period. The preoperative assessment, surgery, and discounted follow‐up costs associated with subthalamic nucleus surgery were estimated at approximately £32,526 per patient over 5 years. Almost 70% of these costs are attributable to the initial costs of the equipment and the likely follow‐up and replacement costs of the equipment. These costs will be affected mainly by future equipment costs and their replacement period and are relatively insensitive to preoperative assessment staff costs, length of hospital stay after surgery, and imaging costs. This cost estimate should be of use to researchers, health care managers, policy makers, and surgeons working in this area. Providing an estimate of the cost of this new procedure will provide a baseline for tracking future changes in costs and will assist the production of cost‐effectiveness estimates. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10481
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001165
- to stream Istex, to step Curation: 001165
- to stream Istex, to step Checkpoint: 002A24
- to stream PubMed, to step Corpus: 003702
- to stream PubMed, to step Curation: 003702
- to stream PubMed, to step Checkpoint: 003783
- to stream Ncbi, to step Merge: 000B62
- to stream Ncbi, to step Curation: 000B62
- to stream Ncbi, to step Checkpoint: 000B62
- to stream Main, to step Merge: 005D17
- to stream PascalFrancis, to step Corpus: 002388
- to stream PascalFrancis, to step Curation: 000933
- to stream PascalFrancis, to step Checkpoint: 002459
- to stream Main, to step Merge: 006005
- to stream Main, to step Curation: 004094
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease</title><author><name sortKey="Mcintosh, Emma" sort="Mcintosh, Emma" uniqKey="Mcintosh E" first="Emma" last="Mcintosh">Emma Mcintosh</name></author><author><name sortKey="Gray, Alastair" sort="Gray, Alastair" uniqKey="Gray A" first="Alastair" last="Gray">Alastair Gray</name></author><author><name sortKey="Aziz, Tipu" sort="Aziz, Tipu" uniqKey="Aziz T" first="Tipu" last="Aziz">Tipu Aziz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CC27B12540C5353350C5C6DC366692131C0A0E50</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10481</idno><idno type="url">https://api.istex.fr/document/CC27B12540C5353350C5C6DC366692131C0A0E50/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001165</idno><idno type="wicri:Area/Istex/Curation">001165</idno><idno type="wicri:Area/Istex/Checkpoint">002A24</idno><idno type="wicri:doubleKey">0885-3185:2003:Mcintosh E:estimating:the:costs</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14502666</idno><idno type="wicri:Area/PubMed/Corpus">003702</idno><idno type="wicri:Area/PubMed/Curation">003702</idno><idno type="wicri:Area/PubMed/Checkpoint">003783</idno><idno type="wicri:Area/Ncbi/Merge">000B62</idno><idno type="wicri:Area/Ncbi/Curation">000B62</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B62</idno><idno type="wicri:doubleKey">0885-3185:2003:Mcintosh E:estimating:the:costs</idno><idno type="wicri:Area/Main/Merge">005D17</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0054201</idno><idno type="wicri:Area/PascalFrancis/Corpus">002388</idno><idno type="wicri:Area/PascalFrancis/Curation">000933</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002459</idno><idno type="wicri:doubleKey">0885-3185:2003:Mcintosh E:estimating:the:costs</idno><idno type="wicri:Area/Main/Merge">006005</idno><idno type="wicri:Area/Main/Curation">004094</idno><idno type="wicri:Area/Main/Exploration">004094</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease</title><author><name sortKey="Mcintosh, Emma" sort="Mcintosh, Emma" uniqKey="Mcintosh E" first="Emma" last="Mcintosh">Emma Mcintosh</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Health Economics Research Centre, University of Oxford, Institute of Health Sciences, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Gray, Alastair" sort="Gray, Alastair" uniqKey="Gray A" first="Alastair" last="Gray">Alastair Gray</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Health Economics Research Centre, University of Oxford, Institute of Health Sciences, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Aziz, Tipu" sort="Aziz, Tipu" uniqKey="Aziz T" first="Tipu" last="Aziz">Tipu Aziz</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurosurgery, The Radcliffe Infirmary, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-09">2003-09</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="993">993</biblScope><biblScope unit="page" to="999">999</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">CC27B12540C5353350C5C6DC366692131C0A0E50</idno><idno type="DOI">10.1002/mds.10481</idno><idno type="ArticleID">MDS10481</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advanced stage</term><term>Cost efficiency analysis</term><term>Cost estimation</term><term>Costs</term><term>Data Collection</term><term>Electric Stimulation Therapy</term><term>Electrical stimulus</term><term>Electrodes, Implanted</term><term>Health Care Costs</term><term>Health economy</term><term>Hospitals (statistics & numerical data)</term><term>Human</term><term>Humans</term><term>Instrumentation therapy</term><term>Neurosurgical Procedures (economics)</term><term>Parkinson Disease (economics)</term><term>Parkinson Disease (surgery)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Severity of Illness Index</term><term>Subthalamic Nucleus (surgery)</term><term>Subthalamic nucleus</term><term>Treatment Outcome</term><term>United Kingdom</term><term>cost</term><term>subthalamic stimulation</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Neurosurgical Procedures</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitals</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Parkinson Disease</term><term>Subthalamic Nucleus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Data Collection</term><term>Electric Stimulation Therapy</term><term>Electrodes, Implanted</term><term>Health Care Costs</term><term>Humans</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Analyse coût efficacité</term><term>Coût</term><term>Economie santé</term><term>Estimation coût</term><term>Homme</term><term>Noyau sousthalamique</term><term>Parkinson maladie</term><term>Royaume Uni</term><term>Stade avancé</term><term>Stimulus électrique</term><term>Traitement instrumental</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We estimated the current cost of deep brain stimulation surgery targeted on the subthalamic nucleus. The method used was a cost analysis using typical resource use patterns and unit costs from a leading surgical centre, detailed equipment costs from the manufacturer, and sensitivity analysis. Resource use was based on patients with advanced Parkinson's disease. The main outcome measure was the likely total health service costs per patient, including preoperative assessment, surgery, and postoperative management over a 5‐year period. The preoperative assessment, surgery, and discounted follow‐up costs associated with subthalamic nucleus surgery were estimated at approximately £32,526 per patient over 5 years. Almost 70% of these costs are attributable to the initial costs of the equipment and the likely follow‐up and replacement costs of the equipment. These costs will be affected mainly by future equipment costs and their replacement period and are relatively insensitive to preoperative assessment staff costs, length of hospital stay after surgery, and imaging costs. This cost estimate should be of use to researchers, health care managers, policy makers, and surgeons working in this area. Providing an estimate of the cost of this new procedure will provide a baseline for tracking future changes in costs and will assist the production of cost‐effectiveness estimates. © 2003 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Oxfordshire</li></region><settlement><li>Oxford</li></settlement><orgName><li>Université d'Oxford</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Mcintosh, Emma" sort="Mcintosh, Emma" uniqKey="Mcintosh E" first="Emma" last="Mcintosh">Emma Mcintosh</name></region><name sortKey="Aziz, Tipu" sort="Aziz, Tipu" uniqKey="Aziz T" first="Tipu" last="Aziz">Tipu Aziz</name><name sortKey="Gray, Alastair" sort="Gray, Alastair" uniqKey="Gray A" first="Alastair" last="Gray">Alastair Gray</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004094 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004094 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:CC27B12540C5353350C5C6DC366692131C0A0E50
|texte= Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |